GALEN Partners III L P, 10% Owner at ACURA PHARMACEUTICALS, INC (ACUR), sold 31,559 shares at $2.25 ($71K) on 2013-05-31, disclosed to the SEC on 2013-06-03.
Open-market sale of $71k ACUR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.26 | 12,860 | $29K | 40.9% |
| 2 | $2.25 | 18,699 | $42K | 59.1% |
| Total | $2.25 avg | 31,559 | $71K | 100% |
| Filing → |
| ACUR | SELL | 2013-06-19 | $44K | — | Filing → |
| ACUR | SELL | 2013-05-15 | $427K | — | Filing → |
| ACUR | SELL | 2013-04-19 | $764K | — | Filing → |